KMT2C and neoplasm: In addition, late clones were observed to have mutations specifically in ASH1L, KMT2C[68] and KMD4B.[69] The accumulation of mutations in these epigenetic regulatory genes, particularly in late clones, suggests that these modifications may provide tumor cells with selective benefits, allowing them to bypass growth and survival hurdles.